Alaska pollock protein as a functional dietary source for promoting skeletal muscle hypertrophy and lipid metabolic remodeling

A Ayumu Kojima R Risa Mukai M Mizuki Morisasa W Wakako Tawara S Shunsuke Amagaya K Kenjiro Furusho N Norika Tsutsumi Y Yukina Tadokoro H Haruto Otsuka M Miu Fujii T Taro Kishida A Atsushi Kuno (Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology) A Azusa Tomioka S Shinji Okada T Tsukasa Mori N Naoko Goto-Inoue

Abstract

Alaska pollock protein (APP) promotes skeletal muscle hypertrophy, particularly in fast-twitch fibers. Using a time-controlled feeding model, plasma collected 90 min after APP intake markedly enhanced C2C12 myotube hypertrophy and contractility. At this time point, plasma glucagon-like peptide-1 levels were significantly elevated, suggesting the involvement of circulating factors associated with APP intake. Proteomic and lipidomic analyses of skeletal muscle identified 2302 proteins and 538 lipids, and revealed pronounced remodeling of lipid metabolism, including a 127% increase in docosahexaenoic acid (DHA)-containing phospholipids in hypertrophied fast-twitch fibers, partially resembling endurance training adaptations. APP also upregulated adipose triglyceride lipase and hormone-sensitive lipase in the skeletal muscle, indicating enhanced lipid catabolism. Although APP contained only trace amounts of DHA (~0.008% of the diet), this level was substantially lower than the dietary DHA level previously reported to alter tissue lipid composition. Therefore, APP-derived DHA was unlikely to be the primary driver of the observed phenotype. Together, these findings indicate that APP functions primarily as a high-quality protein source that promotes muscle anabolic responses and is associated with remodeling of lipid metabolic pathways, thereby potentially contributing to a circulating environment favorable for skeletal muscle hypertrophy and metabolic regulation.

Article Details

Journal PLoS ONE
Volume / Issue Vol. 21, Issue 5
Published May 13, 2026
Pages e0348366
ISSN 1932-6203
Publisher Public Library of Science

Journal Info

PLoS ONE

Public Library of Science

ISSN: 1932-6203 Open Access Health Sciences

Authors (16)

A

Ayumu Kojima

R

Risa Mukai

M

Mizuki Morisasa

W

Wakako Tawara

S

Shunsuke Amagaya

K

Kenjiro Furusho

N

Norika Tsutsumi

Y

Yukina Tadokoro

H

Haruto Otsuka

M

Miu Fujii

T

Taro Kishida

A

Atsushi Kuno

Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology

A

Azusa Tomioka

S

Shinji Okada

T

Tsukasa Mori

N

Naoko Goto-Inoue